Epidemiological situation of the Covid-19 infection and effectiveness of public health strategies
Keywords:
: Epidemiological; Pandemic; Pathologies; Mortality; Infections.Abstract
In the present investigation, the information on systematizing the evidence reported on the epidemiology of Covid-19infection and the effectiveness of public health strategies was analyzed. Following the identification of a new coronavirus, the disease was designated coronavirus-19, the spread and severity of which led the World Health Organization (WHO) to declare it an international emergency on January 30, 2020. The current report describes the epidemiology of patients and confirms the Coronavirus 2019: 5.91% of the world population (7,965,424,797) was infected and the mortality rate was 1.29%. One of the countries with the most infections in 2022 is Germany with 37.49% of the population and a mortality rate of 0.46%. At the beginning of the pandemic, 56,935 infections and 2.89 percent of deaths were reported, according to detailed data provided by INEC Ecuador for 2020. It was concluded that the prevalence of patients with Covid-19continues to be predominantly male, as is than in other cases reported in different parts of the world, in addition to a series of other diseases, mainly overweight as a risk factor in the disease studied.
Downloads
References
Beasain J, V. M. (2021). Estrategias preventivas en los componentes de la triada ecológica ante la COVID-19. Revista Cubana de Pediatría, 93(2).
Echevarría Ibazeta, R. R. (2020). Situación epidemiológica del Covid-19 en Sudamérica. Revista de la Facultad de Medicina Humana:, 20(3)(Available at: https://inicib.urp.edu.pe/rfmh/vol20/iss3/27).
G., Z. (2020). Tomar medidas preventivas inmediatamente: evidencia de China sobre el COVID-19. Gaceta Sanitaria, 34(3): p. 217-219.
Guevara M, G. M. (2021). La promoción de la salud en el contexto de la pandemia de COVID-19. Espacio Abierto, 30(2): p. 66-86. .
J., L. (2021). La pandemia coronavirus Covid-19 y salud del medio ambiente. Educere, 25(80): p. 259-262.
Lu R, Z. X. (2020). Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet., 395(10224):565-574.
Medeiros A, D. A. (2021). Letalidad de la COVID-19: ausencia de patrón epidemiológico. Gaceta Sanitaria, 35(4): p. 355-357.
MSP, M. d. (2020 [citado 2021 diciembre 10]. ). Obtenido de https://www.salud.gob.ec/actualizaci%F3n-de-casos-de-coronavirus-en-ecuador/
OMS, O. M. (2020 [cited 2021). Coronavirus. [Online] diciembre 10].
OMS, O. M. (2020 [cited 2021 diciembre 10]). Los nombres de la enfermedad por coronavirus (COVID-19) y del virus que la causa. Obtenido de https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(Covid-19)-and-the-virus-that-causes-it
OPS, O. P. (2020 [cited 2021 diciembre 10]). Coronavirus. [Online]. Obtenido de https://www.paho.org/es/temas/coronavirus
Rodríguez R, P. A. (2020). Características epidemiológicas y demográficas de pacientes con Covid-19: Un estudio comparativo entre Jipijapa y Puerto López. Revista. Dominio de las Ciencias., 6(4): 1170-1184.
Valero C, M. O. (2020). COVID-19: La nueva pandemia con muchas lecciones y nuevos retos. Revisión Narrativa. Kasmera, 48(1) e48102042020.
Valero-Cedeño NJ, M.-O. J.-C.-V. (2020). COVID-19: La nueva pandemia con muchas lecciones y nuevos retos. Revisión Narrativa. Kasmera, 48(1)e48102042020.
Wai K Leung, K.-f. T. (2018). Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterología, 125(4) 1011-1017.
Walls A, P. Y. (2020). Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell., 181(2):281292.e6.
Walls AC, P. Y. (2020). Structure Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell, 181(2):281-292.e6
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Científica Arbitrada Multidisciplinaria PENTACIENCIAS - ISSN 2806-5794.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

